Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,951,054 papers from all fields of science
Search
Sign In
Create Free Account
Viral Oncolysate
An extract made from cancer cells that are infected with a strain of virus that can lyse (break down) cancer cells. The extract contains both cancer…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Dendritic Cells Pulsed with Viral Oncolysate
P. Fournier
,
V. Schirrmacher
2013
Corpus ID: 73816692
Glioblastoma multiforme (GBM) is an aggressive malignant tumour of the central neural system (CNS). Despite an improved surgical…
Expand
Review
1999
Review
1999
Cancer vaccines with emphasis on a viral oncolysate melanoma vaccine.
J. Horvath
,
A. Horák
,
J. Sinkovics
,
M. Pritchard
,
S. Pendleton
,
E. Horváth
Acta Microbiologica et Immunologica Hungarica
1999
Corpus ID: 34808585
Biotherapy of malignant diseases has become the fourth treatment modality besides surgery, chemo- and radiotherapy. Whole cell…
Expand
1993
1993
Active intralymphatic immunotherapy of uterine cervical carcinoma with viral oncolysate: a pilot study
R. Freedman
,
J. Bowen
,
+7 authors
R. Patenia
International Journal of Gynecologic Cancer
1993
Corpus ID: 21180366
A pilot clinical trial was conducted in patients with squamous carcinoma of the uterine cervix to evaluate the clinical and…
Expand
1991
1991
Immunological effects of tumor vaccines: III. Influenza virus oncolysates inhibit the TPA induced activation of peripheral blood mononuclear cells.
Ioannides Cg
,
R. Freedman
,
R. Patenia
,
J. Bowen
,
Ward Ne
,
O'Brian Ca
In Vivo
1991
Corpus ID: 43461361
This paper investigates the effects of tumor vaccines on T cell proliferation induced by 12-0 tetradecanoylphorbol-13-acetate…
Expand
1989
1989
Randomized Comparison of Viral Oncolysate plus Radiation and Radiation Alone in Uterine Cervix Carcinoma
R. Freedman
,
J. Bowen
,
+9 authors
J. Wharton
American Journal of Clinical Oncology
1989
Corpus ID: 10051883
A randomized, controlled study was performed in patients with high-risk, untreated squamous cell carcinoma of the uterine cervix…
Expand
1989
1989
Lymphokine activity in malignant effusions after intracavitary viral oncolysate.
R. Freedman
,
N. Kouttab
,
J. Bowen
,
C. Edwards
,
R. Katz
Lymphokine research
1989
Corpus ID: 6245314
Six patient with malignant effusions (five with ascites and one with malignant pleural effusion) due to refractory ovarian…
Expand
1989
1989
Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatment.
C. Ioannides
,
C. Platsoucas
,
J. Bowen
,
J. Wharton
,
R. Freedman
Anticancer Research
1989
Corpus ID: 31494511
Antibodies reacting with the cell surface of ovarian tumor cell lines were detected in the sera of untreated patients with…
Expand
1989
1989
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies.
H. Seigler
,
M. Wallack
,
C. Vervaert
,
J. Bash
,
K. M. Roberson
,
G. M. Stuhlmiller
Journal of Biological Response Modifiers
1989
Corpus ID: 41405794
Sera from melanoma patients undergoing immunization with three distinct immunogens were evaluated for development of IgG antibody…
Expand
1986
1986
Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate
W. Cassel
,
K. Weidenheim
,
W. G. Campbell
,
D. Murray
Cancer
1986
Corpus ID: 22763718
Five patients with advanced malignant melanomatreated with viral oncolysatehad solitary central nervous system metastases that…
Expand
1983
1983
Early antiviral antibody response after immunization with viral oncolysate: a powerful prognostic marker for acute myelogenous leukemia remission patients.
J. Schuepbach
,
S. Arrenbrecht
,
C. Sauter
Blood
1983
Corpus ID: 29930545
Twenty-four acute myelogenous leukemia (AML) patients in first clinical remission received, as a part of their maintenance…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE